恒瑞医药副总经理全球研发总裁张连山博士：诚邀您出席2022第三届中国新药CMC高峰论坛！
<img class="rich_pages wxw-img" data-backh="19" data-backw="578" data-galleryid="" data-ratio="0.03333333333333333" data-s="300,640" src="https://zfz-oss.oss-cn-hangzhou.aliyuncs.com/temp/d2b47a0ab0c698c48c0b3c55591763ed.png" data-type="png" data-w="1080" style="font-size: 16px;outline: 0px;text-align: center;letter-spacing: 0.544px;display: initial;width: 100%;box-sizing: border-box !important;visibility: visible !important;height: auto;"/></section></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-size: 15px;font-family: " yahei="">本周，各大药企陆续公布第三季度财报。</span></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-size: 15px;font-family: " yahei="">作为“OK药”正主的百时美施贵宝（BMS）与默沙东(MRK.US)也于本周相继公布了第三季度财报。</span></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-size: 15px;font-family: " yahei="">2022年10月25日，BMS公布第三季度财报。财报显示，第三季度总销售收入为112亿美元，同比下降3%。</span></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-size: 15px;font-family: " yahei="">就销售占比而言，主力还是抗凝药Eliquis和PD-1单抗Opdivo（O药）。其中Eliquis <span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">前三个季度</span>累积销售达90.72亿美元，O药前三个季度<span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">累积</span>销售60.33亿美元。</span></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-size: 15px;font-family: " yahei="">尽管O药在销售额上略逊一筹，BMS<span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">还是</span>一直致力于拓展其适应症和使用范围。<span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">自2014年</span><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">在</span><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">日本获批后</span><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">，</span>作为全球首款PD-1单抗抗癌药，O药不断有新适应症获批。今年6月，O药<span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">又</span>在中国拿下了两大食管癌适应症，进一步提升了上消化道肿瘤免疫治疗适应症覆盖率。</span></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><img class="rich_pages wxw-img" data-backh="327" data-backw="578" data-ratio="0.5654574132492114" src="https://zfz-oss.oss-cn-hangzhou.aliyuncs.com/temp/8b5d3523257784c487e49f40d8006410.png" data-type="png" data-w="1268" style="width: 100%;height: auto;"/></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-size: 15px;font-family: " yahei="">据不完全统计，O药已在全球超过65个国家和地区获批，适应症涵盖了11个瘤种。并且，还有许多适应症处于三期临床试验中。</span></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-size: 15px;font-family: " yahei="">当然，BMS的Q3财报整体还是呈下滑状态。主要原因在于重磅炸弹Revlimid（来那度胺）受仿制药冲击，<span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">较2</span><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">021年Q3</span><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">，<span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">其国际收入</span></span><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">同比下降高达76%，</span>为2.5亿美元。</span></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><img class="rich_pages wxw-img" data-backh="333" data-backw="578" data-ratio="0.5755905511811024" src="https://zfz-oss.oss-cn-hangzhou.aliyuncs.com/temp/5da12acbe6278f9fb8c540d0360d8484.png" data-type="png" data-w="1270" style="width: 100%;height: auto;"/></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-size: 15px;font-family: " yahei="">去年还给BMS带来了128亿美元的销售额的Revlimid，今年年初就开始一路走低，半年销售额为52.98亿美元，同比下跌14%。反观Teva的仿制药销量，则上涨明显。</span></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-size: 15px;font-family: " yahei="">这多少让BMS有点心塞。</span></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-size: 15px;font-family: " yahei="">几家欢喜几家忧，“老对头”默沙东也于2022年10月27日公布第三季度业绩。</span></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-size: 15px;font-family: " yahei="">财报显示，第三季度总销售收入为149.59亿美元，同比增长14%。预计全年全球销售额约为585- 590亿美元之间，同比增长20%-21%。</span></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><img class="rich_pages wxw-img" data-backh="343" data-backw="578" data-ratio="0.5933806146572104" src="https://zfz-oss.oss-cn-hangzhou.aliyuncs.com/temp/7cb62c239b122fe5dfa64c715848f57a.png" data-type="png" data-w="1269" style="width: 100%;height: auto;"/></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-size: 15px;font-family: " yahei="">作为默沙东的主要营收点，Keytruda（K药）Q3销售额为54亿美元，同比增长20%；GARDASIL/GARDASIL 9(HPV疫苗)销售额为23亿美元，同比增长15%。</span></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-size: 15px;font-family: " yahei="">虽然新冠口服药LAGEVRIO受辉瑞Paxlovid影响，销售额暴跌，2022Q1本为32.47亿美元、Q3却已经跌到4.36亿美元。但上观K药瞩目的数据，K药有望取代修美乐，成为全球最畅销的下一代“药王”。</span></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-size: 15px;font-family: " yahei="">如今，“OK”竞技已过8个年头。从起初BMS凭借先发优势率先占领市场，到后来在非小细胞肺癌上受挫，K药借机反超。经典反映了医药市场中 “得适应症者得天下”的游戏规则。</span></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-size: 15px;font-family: " yahei=""><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">目前</span><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">，K药获批适应症数量已近O药</span><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">2倍。</span>O药好像已经折戟沉沙，在适应症的数量上被默沙东远远甩开。</span></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-size: 15px;font-family: " yahei="">K药后来者居上，O药却没发挥好先发优势，原因为何？</span></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: 2em;"><br/></section><p style="margin-top: 0px;margin-bottom: 16px;line-height: 1.5em;"><em><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">参考资料：</span></em></p><section style="margin-top: 0px;margin-bottom: 16px;line-height: normal;"><em><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">1.默沙东官网</span></em></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: normal;"><em><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">2.BMS官网</span></em></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: normal;"><em><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">3.智慧芽官网</span></em></section><section style="margin-top: 0px;margin-bottom: 16px;line-height: normal;"><em><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">4.仿制药冲击来袭，BMS来那度胺百亿辉煌不再，创新产品持续发力（网易）</span></em></section><h1 style="margin-top: 0px;margin-bottom: 16px;line-height: normal;"><em><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">5.默沙东Q3销售额同比增长14%超预期 新冠口服药销售额4.36亿美元（新浪财经）</span></em></h1><h1 style="margin-top: 0px;margin-bottom: 16px;line-height: normal;"><em><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="font-family: " yahei="">6.其他公开资料</span></em></h1><p arial="" gb="" helvetica="" neue="" normal="" rgb="" sans="" sans-serif="" sc="" style="margin-top: 8px;margin-bottom: 0px;outline: 0px;color: rgb(34, 34, 34);font-family: system-ui, -apple-system, BlinkMacSystemFont, " ui="" visible="" yahei=""><img class="rich_pages wxw-img" data-backh="19" data-backw="578" data-galleryid="" data-ratio="0.03333333333333333" data-s="300,640" src="https://zfz-oss.oss-cn-hangzhou.aliyuncs.com/temp/d2b47a0ab0c698c48c0b3c55591763ed.png" data-type="png" data-w="1080" style="outline: 0px;text-align: center;letter-spacing: 0.544px;display: initial;box-sizing: border-box !important;width: 100%;visibility: visible !important;height: auto;"/></p><section arial="" gb="" helvetica="" neue="" normal="" powered-by="xiumi.us" rgb="" sans="" sans-serif="" sc="" style="margin-bottom: 0px;outline: 0px;color: rgb(34, 34, 34);font-family: system-ui, -apple-system, BlinkMacSystemFont, " ui="" yahei=""><section arial="" gb="" helvetica="" neue="" rgba="" right="" sans="" sans-serif="" sc="" style="outline: 0px;letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, " ui="" yahei=""><span style="outline: 0px;font-size: 12px;color: rgb(136, 136, 136);"><span style="outline: 0px;letter-spacing: 0.544px;">封面图来源</span><em arial="" gb="" helvetica="" neue="" sans="" sans-serif="" sc="" style="outline: 0px;letter-spacing: 0.544px;font-family: system-ui, -apple-system, BlinkMacSystemFont, " ui="" yahei=""><span arial="" center="" gb="" helvetica="" neue="" normal="" sans="" sans-serif="" style="outline: 0px;letter-spacing: 1px;font-family: " yahei="">：<em arial="" gb="" helvetica="" neue="" right="" sans="" sans-serif="" sc="" style="outline: 0px;font-family: system-ui, -apple-system, BlinkMacSystemFont, " ui="" yahei=""><span arial="" center="" gb="" helvetica="" neue="" normal="" sans="" sans-serif="" style="outline: 0px;letter-spacing: 1px;font-family: " yahei=""><em arial="" gb="" neue="" right="" sans="" sans-serif="" sc="" style="outline: 0px;font-family: system-ui, -apple-system, " system-ui="" ui="" yahei=""><span arial="" center="" gb="" helvetica="" neue="" normal="" sans="" sans-serif="" style="outline: 0px;letter-spacing: 1px;font-family: " yahei="">123rf</span></em></span></em></span></em></span><br style="outline: 0px;"/></section><p arial="" center="" gb="" helvetica="" neue="" rgba="" sans="" sans-serif="" sc="" style="outline: 0px;letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, " ui="" yahei=""><a data-itemshowtype="0" data-linktype="1" href="http://mp.weixin.qq.com/s?__biz=MzI5NzY0NDQyNQ==&mid=2248025110&idx=2&sn=e561db226298949039dbfa9ecefeb6b4&chksm=ecbb7cf0dbccf5e6ebed5b94cd6a58db729cf8e2af9acd0f143018cf569dfc4639532cd0c004&scene=21#wechat_redirect" imgdata="null" imgurl="" linktype="text" tab="innerlink" target="_blank" textvalue="你已选中了添加链接的内容"><span class="js_jump_icon h5_image_link" data-positionback="static" style="outline: 0px;line-height: 0;vertical-align: bottom;user-select: none;inset: auto;"><img class="rich_pages wxw-img" data-backh="215" data-backw="578" data-galleryid="" data-ratio="0.3712962962962963" data-s="300,640" src="https://zfz-oss.oss-cn-hangzhou.aliyuncs.com/temp/3a964563c1bc53dd507a1cde9db212ee.jpeg" data-type="jpeg" data-w="1080" style="outline: 0px;border-width: 0px;border-style: initial;border-color: initial;display: initial;width: 100%;inset: auto;box-sizing: border-box !important;visibility: visible !important;height: auto;"/></span></a></p><section arial="" center="" gb="" helvetica="" neue="" rgb="" sans="" sans-serif="" sc="" style="margin-top: 8px;outline: 0px;letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, " ui="" visible="" yahei=""><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="outline: 0px;font-size: 12px;color: rgb(136, 136, 136);letter-spacing: 1px;font-family: " visible="" yahei=""><strong style="outline: 0px;letter-spacing: 0.544px;caret-color: rgba(0, 0, 0, 0);color: rgb(0, 0, 0);font-size: 15px;visibility: visible;"><span style="outline: 0px;text-decoration: underline;visibility: visible;"><strong mpa-from-tpl="t" msthash="3185793" msttexthash="30069806" style="outline: 0px;visibility: visible;">版权声明/免责声明</strong></span></strong></span></section><section arial="" center="" gb="" helvetica="" neue="" rgb="" sans="" sans-serif="" sc="" style="margin-top: 8px;outline: 0px;letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, " ui="" visible="" yahei=""><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="outline: 0px;font-size: 12px;color: rgb(136, 136, 136);letter-spacing: 1px;font-family: " visible="" yahei="">本文为原创文章，版权归拥有者。</span></section><section arial="" center="" gb="" helvetica="" neue="" rgb="" sans="" sans-serif="" sc="" style="outline: 0px;letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, " ui="" visible="" yahei=""><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="outline: 0px;font-size: 12px;color: rgb(136, 136, 136);letter-spacing: 1px;font-family: " visible="" yahei="">仅供感兴趣的个人谨慎参考，非商用，非医用、非投资用。</span></section><section arial="" center="" gb="" helvetica="" neue="" rgb="" sans="" sans-serif="" sc="" style="outline: 0px;letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, " ui="" visible="" yahei=""><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="outline: 0px;font-size: 12px;color: rgb(136, 136, 136);letter-spacing: 1px;font-family: " visible="" yahei="">欢迎朋友们批评指正！衷心感谢！</span></section><section arial="" center="" gb="" helvetica="" neue="" rgb="" sans="" sans-serif="" sc="" style="outline: 0px;letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, " ui="" visible="" yahei=""><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="outline: 0px;font-size: 12px;color: rgb(136, 136, 136);letter-spacing: 1px;font-family: " visible="" yahei="">文中图片、视频为授权正版作品，或来自微信公共图片库，或取自公司官网/网络</span></section><section arial="" center="" gb="" helvetica="" neue="" rgb="" sans="" sans-serif="" sc="" style="outline: 0px;letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, " ui="" visible="" yahei=""><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="outline: 0px;font-size: 12px;color: rgb(136, 136, 136);letter-spacing: 1px;font-family: " visible="" yahei="">根据CC0协议使用，版权归拥有者。</span></section><section arial="" center="" gb="" helvetica="" neue="" rgb="" sans="" sans-serif="" sc="" style="outline: 0px;letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, " ui="" visible="" yahei=""><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="outline: 0px;font-size: 12px;color: rgb(136, 136, 136);letter-spacing: 1px;font-family: " visible="" yahei="">任何问题，请与我们联系（电话：13651980212。微信：27674131。邮箱：contact@drugtimes.cn）。衷心感谢！</span></section><p arial="" gb="" helvetica="" neue="" rgb="" sans="" sans-serif="" sc="" style="margin-bottom: 8px;outline: 0px;letter-spacing: 0.544px;text-align: center;font-family: -apple-system, system-ui, " ui="" visible="" yahei=""><span arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="outline: 0px;color: rgb(74, 75, 76);visibility: visible;font-size: 15px;font-family: " yahei=""><img class="rich_pages wxw-img __bg_gif" data-galleryid="" data-ratio="1" src="https://zfz-oss.oss-cn-hangzhou.aliyuncs.com/temp/aa868c8da79e721edd14a9f1a5f808c7.gif" data-type="gif" data-w="128" style="outline: 0px;color: rgb(136, 136, 136);letter-spacing: 0.544px;display: initial;box-sizing: border-box !important;visibility: visible !important;width: 57.7969px !important;"/></span></p><section arial="" gb="" neue="" sans="" sans-serif="" sc="" style="outline: 0px;letter-spacing: 0.544px;text-align: center;caret-color: rgba(0, 0, 0, 0);font-family: system-ui, -apple-system, " system-ui="" ui="" yahei=""><br style="outline: 0px;"/></section><section arial="" gb="" neue="" sans="" sans-serif="" sc="" style="outline: 0px;letter-spacing: 0.544px;text-align: center;caret-color: rgba(0, 0, 0, 0);font-family: system-ui, -apple-system, " system-ui="" ui="" yahei=""><span arial="" gb="" helvetica="" neue="" rgb="" sans="" sans-serif="" style="outline: 0px;font-size: 15px;font-family: " visible="" yahei=""><em style="outline: 0px;visibility: visible;"><span style="outline: 0px;font-style: normal;visibility: visible;"><strong arial="" gb="" neue="" sans="" sans-serif="" sc="" style="outline: 0px;color: rgb(255, 41, 65);font-family: system-ui, -apple-system, " system-ui="" ui="" visible="" yahei=""><em arial="" gb="" helvetica="" neue="" rgb="" sans="" sans-serif="" style="outline: 0px;font-family: " visible="" yahei=""><span style="outline: 0px;font-style: normal;visibility: visible;"><strong arial="" gb="" neue="" sans="" sans-serif="" sc="" style="outline: 0px;color: rgb(255, 41, 65);font-family: system-ui, -apple-system, " system-ui="" ui="" visible="" yahei=""><strong style="outline: 0px;letter-spacing: 0.544px;font-size: 15px;visibility: visible;"><strong arial="" gb="" helvetica="" neue="" sans="" sans-serif="" sc="" style="outline: 0px;color: rgb(34, 34, 34);letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, " ui="" visible="" yahei=""><img class="__bg_gif rich_pages wxw-img" data-ratio="1.2105263157894737" src="https://zfz-oss.oss-cn-hangzhou.aliyuncs.com/temp/07ca4375e6f96f87029b82ed898282fc.gif" data-type="gif" data-w="38" style="margin-right: 6px;outline: 0px;vertical-align: middle;letter-spacing: 0.544px;display: initial;box-sizing: border-box !important;visibility: visible !important;width: 30px !important;"/></strong></strong></strong></span></em>博腾股份小分子事业部副总经理 史峰博士</strong></span></em></span><em arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="outline: 0px;color: rgb(136, 136, 136);font-family: " visible="" yahei=""><span style="outline: 0px;font-style: normal;visibility: visible;"><strong arial="" gb="" neue="" sans="" sans-serif="" sc="" style="outline: 0px;color: rgb(255, 41, 65);font-family: system-ui, -apple-system, " system-ui="" ui="" visible="" yahei="">：诚邀您出席2022第三届中国新药CMC高峰论坛！</strong></span></em></section><section><iframe allowfullscreen="" class="video_iframe rich_pages" data-cover="http%3A%2F%2Fmmbiz.qpic.cn%2Fmmbiz_jpg%2FLkw2iaE07M9XEcG7rBuJ29LTt8oGQUT83iaXHw2KOYciadc2dZk8caWeYFgyLoegE6cS1ZibhCeUticZt4LglCjhhSA%2F0%3Fwx_fmt%3Djpeg" data-mpvid="wxv_2638098279867891715" data-ratio="1.7777777777777777" data-src="https://mp.weixin.qq.com/mp/readtemplate?t=pages/video_player_tmpl&action=mpvideo&auto=0&vid=wxv_2638098279867891715" data-vidtype="2" data-w="1920" frameborder="0" style="border-radius: 4px;"/></section><p style="outline: 0px;letter-spacing: 0.544px;visibility: visible;text-align: center;"><span arial="" gb="" helvetica="" neue="" rgb="" rgba="" sans="" sans-serif="" style="outline: 0px;font-size: 15px;font-family: " visible="" yahei=""><em style="outline: 0px;visibility: visible;"><span style="outline: 0px;font-style: normal;visibility: visible;"><strong arial="" gb="" neue="" sans="" sans-serif="" sc="" style="outline: 0px;color: rgb(255, 41, 65);font-family: system-ui, -apple-system, " system-ui="" ui="" visible="" yahei=""><em arial="" gb="" helvetica="" neue="" rgb="" sans="" sans-serif="" style="outline: 0px;font-family: " visible="" yahei=""><span style="outline: 0px;font-style: normal;visibility: visible;"><strong arial="" gb="" neue="" sans="" sans-serif="" sc="" style="outline: 0px;color: rgb(255, 41, 65);font-family: system-ui, -apple-system, " system-ui="" ui="" visible="" yahei=""><strong style="outline: 0px;letter-spacing: 0.544px;font-size: 15px;visibility: visible;"><strong arial="" gb="" helvetica="" neue="" sans="" sans-serif="" sc="" style="outline: 0px;color: rgb(34, 34, 34);letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, " ui="" visible="" yahei=""><img class="__bg_gif rich_pages wxw-img" data-ratio="1.2105263157894737" src="https://zfz-oss.oss-cn-hangzhou.aliyuncs.com/temp/07ca4375e6f96f87029b82ed898282fc.gif" data-type="gif" data-w="38" style="margin-right: 6px;outline: 0px;vertical-align: middle;letter-spacing: 0.544px;display: initial;box-sizing: border-box !important;visibility: visible !important;width: 30px !important;"/></strong></strong></strong></span></em>前FDA检查官 Live Oak Quality Assurance 创始人兼总裁<span style="outline: 0px;letter-spacing: 1px;visibility: visible;">Peter Baker 先生</span></strong></span></em></span><em arial="" gb="" helvetica="" neue="" sans="" sans-serif="" style="outline: 0px;color: rgb(136, 136, 136);caret-color: rgba(0, 0, 0, 0);font-family: " visible="" yahei=""><span style="outline: 0px;font-style: normal;visibility: visible;"><strong arial="" gb="" neue="" sans="" sans-serif="" sc="" style="outline: 0px;color: rgb(255, 41, 65);font-family: system-ui, -apple-system, " system-ui="" ui="" visible="" yahei="">：诚邀您出席2022第三届中国新药CMC高峰论坛！</strong></span></em></p><section><iframe allowfullscreen="" class="video_iframe rich_pages" data-cover="http%3A%2F%2Fmmbiz.qpic.cn%2Fmmbiz_jpg%2FLkw2iaE07M9U87Lz4H07BypLmoNXDD51vvHI9Map15AxCI3ibGnYdDeLYyuib1icKMcNS9YkJJ0tEtehb2AuLbSZDg%2F0%3Fwx_fmt%3Djpeg" data-mpvid="wxv_2636686834731073541" data-ratio="1.7777777777777777" data-src="https://mp.weixin.qq.com/mp/readtemplate?t=pages/video_player_tmpl&action=mpvideo&auto=0&vid=wxv_2636686834731073541" data-vidtype="2" data-w="1920" frameborder="0" style="border-radius: 4px;"/></section><section arial="" gb="" neue="" sans="" sans-serif="" sc="" style="outline: 0px;letter-spacing: 0.544px;text-align: center;caret-color: rgba(0, 0, 0, 0);font-family: system-ui, -apple-system, " system-ui="" ui="" yahei=""><br/></section><section arial="" center="" gb="" helvetica="" neue="" rgba="" sans="" sans-serif="" sc="" style="margin-bottom: 16px;outline: 0px;letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, " ui="" yahei=""><a data-itemshowtype="0" data-linktype="2" hasload="1" href="http://mp.weixin.qq.com/s?__biz=MzI5NzY0NDQyNQ==&mid=2248019134&idx=1&sn=1e5539fd43be09bea76f8e77fed4da2e&chksm=ecbb5458dbccdd4ed1bf9da296a734b2217dfa0610449be41ebc91d522a7135dbee26f6c7336&scene=21#wechat_redirect" imgdata="null" imgurl="" linktype="text" style="outline: 0px;color: rgb(16, 101, 230);-webkit-tap-highlight-color: rgba(0, 0, 0, 0);cursor: pointer;font-size: 15px;" tab="innerlink" target="_blank" textvalue="不惧内卷，我们勇往向前！——2022第三届中国新药CMC高峰论坛最终日程公布"><span style="outline: 0px;"><strong style="outline: 0px;">不惧<span style="display: none;line-height: 0px;"></span>内卷，我们勇往向前！——2022第三届中国新药CMC高峰论坛最终日程公布</strong></span></a></section><section arial="" center="" gb="" helvetica="" neue="" rgba="" sans="" sans-serif="" sc="" style="margin-bottom: 16px;outline: 0px;letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, " ui="" yahei=""><a data-itemshowtype="0" data-linktype="2" hasload="1" href="http://mp.weixin.qq.com/s?__biz=MzI5NzY0NDQyNQ==&mid=2248025110&idx=2&sn=e561db226298949039dbfa9ecefeb6b4&chksm=ecbb7cf0dbccf5e6ebed5b94cd6a58db729cf8e2af9acd0f143018cf569dfc4639532cd0c004&scene=21#wechat_redirect" imgdata="null" imgurl="" linktype="text" style="outline: 0px;color: rgb(16, 101, 230);-webkit-tap-highlight-color: rgba(0, 0, 0, 0);cursor: pointer;" tab="innerlink" target="_blank" textvalue="参会指南 | 倒计时7天！第三届中国新药CMC高峰论坛参会答疑整理！"><span style="outline: 0px;"><strong style="outline: 0px;">参会指南 | 倒计时7天！第三届中国新药CMC高峰论坛参会答疑整理！</strong></span></a><br style="outline: 0px;"/></section><p arial="" center="" gb="" helvetica="" neue="" rgba="" sans="" sans-serif="" sc="" style="outline: 0px;letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, " ui="" yahei=""><a data-itemshowtype="0" data-linktype="2" hasload="1" href="http://mp.weixin.qq.com/s?__biz=MzI5NzY0NDQyNQ==&mid=2248017744&idx=1&sn=f25375af0fb68ca74f7dca24b1bde5a8&chksm=ecbb5fb6dbccd6a0ee49a55ca18a482916510e3f1fa45c993db19992262976ef7d9c7d0c2754&scene=21#wechat_redirect" imgdata="null" imgurl="" linktype="text" style="outline: 0px;color: rgb(16, 101, 230);-webkit-tap-highlight-color: rgba(0, 0, 0, 0);cursor: pointer;font-size: 15px;" tab="innerlink" target="_blank" textvalue="113本新药好书免费送：《新药的故事1-3》《十亿美元分子》《药明康德经典译丛》……中国新药CMC高峰论坛“十三邀”！"><span style="outline: 0px;"><strong style="outline: 0px;">113本新药好书免费送：《新药的故事1-3》《十亿美元分子》《药明康德经典译丛》……中国新药CMC高峰论坛“十三邀”！</strong></span></a><br style="outline: 0px;"/></p><p arial="" center="" gb="" helvetica="" neue="" rgba="" sans="" sans-serif="" sc="" style="margin-bottom: 8px;outline: 0px;letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, " ui="" yahei=""><a data-itemshowtype="0" data-linktype="1" hasload="1" href="http://mp.weixin.qq.com/s?__biz=MzI5NzY0NDQyNQ==&mid=2248017744&idx=1&sn=f25375af0fb68ca74f7dca24b1bde5a8&chksm=ecbb5fb6dbccd6a0ee49a55ca18a482916510e3f1fa45c993db19992262976ef7d9c7d0c2754&scene=21#wechat_redirect" imgdata="null" imgurl="" linktype="text" style="outline: 0px;-webkit-tap-highlight-color: rgba(0, 0, 0, 0);cursor: pointer;" tab="innerlink" target="_blank" textvalue="你已选中了添加链接的内容"><strong arial="" gb="" helvetica="" neue="" sans="" sans-serif="" sc="" style="outline: 0px;color: rgb(255, 41, 65);font-family: system-ui, -apple-system, BlinkMacSystemFont, " ui="" visible="" yahei=""><span class="js_jump_icon h5_image_link" data-positionback="static" style="outline: 0px;line-height: 0;vertical-align: bottom;user-select: none;inset: auto;"><img class="rich_pages wxw-img" data-backh="246" data-backw="578" data-cropselx1="0" data-cropselx2="520" data-cropsely1="0" data-cropsely2="105" data-galleryid="" data-ratio="0.4255555555555556" data-s="300,640" src="https://zfz-oss.oss-cn-hangzhou.aliyuncs.com/temp/5d8007f071270d05d0c250c2701adfd6.png" data-type="png" data-w="1800" style="outline: 0px;border-width: 0px;border-style: initial;border-color: initial;display: initial;width: 100%;box-sizing: border-box !important;visibility: visible !important;height: auto;"/></span></strong></a></p><p arial="" center="" gb="" helvetica="" neue="" rgba="" sans="" sans-serif="" sc="" style="margin-bottom: 8px;outline: 0px;letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, " ui="" yahei=""><br style="outline: 0px;"/></p><p arial="" center="" gb="" helvetica="" neue="" rgba="" sans="" sans-serif="" sc="" style="outline: 0px;letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, " ui="" yahei=""><strong style="outline: 0px;"><img class="rich_pages wxw-img" data-backh="1570" data-backw="578" data-cropselx1="0" data-cropselx2="578" data-cropsely1="0" data-cropsely2="1570" data-galleryid="" data-ratio="2.7157407407407406" data-s="300,640" src="https://zfz-oss.oss-cn-hangzhou.aliyuncs.com/temp/f527379bc5acb934278c6b1582cad434.jpeg" data-type="jpeg" data-w="1080" style="outline: 0px;width: 100%;display: initial;box-sizing: border-box !important;visibility: visible !important;height: auto;"/></strong></p><section style="outline: 0px;letter-spacing: 0.544px;text-align: center;"><img class="rich_pages wxw-img" data-backh="1235" data-backw="578" data-cropselx1="0" data-cropselx2="578" data-cropsely1="0" data-cropsely2="1235" data-galleryid="" data-ratio="2.136111111111111" data-s="300,640" src="https://zfz-oss.oss-cn-hangzhou.aliyuncs.com/temp/040629eb1e5e4f945a5471bd607f381d.jpeg" data-type="jpeg" data-w="1080" style="outline: 0px;width: 100%;display: initial;box-sizing: border-box !important;visibility: visible !important;height: auto;"/></section><p arial="" gb="" helvetica="" left="" neue="" rgba="" sans="" sans-serif="" sc="" style="margin-top: 8px;outline: 0px;letter-spacing: 0.544px;font-family: -apple-system, BlinkMacSystemFont, " ui="" yahei=""><strong arial="" gb="" helvetica="" neue="" rgb="" sans="" sans-serif="" sc="" style="outline: 0px;font-family: system-ui, -apple-system, BlinkMacSystemFont, " ui="" yahei=""><img class="__bg_gif rich_pages wxw-img" data-fileid="100314835" data-ratio="1.2105263157894737" src="https://zfz-oss.oss-cn-hangzhou.aliyuncs.com/temp/07ca4375e6f96f87029b82ed898282fc.gif" data-type="gif" data-w="38" style="margin-right: 6px;outline: 0px;vertical-align: middle;letter-spacing: 0.544px;display: initial;box-sizing: border-box !important;visibility: visible !important;width: 30px !important;"/></strong><span arial="" gb="" helvetica="" neue="" rgb="" sans="" sans-serif="" sc="" style="outline: 0px;font-family: system-ui, -apple-system, BlinkMacSystemFont, " ui="" yahei=""><strong style="outline: 0px;">点击这里，报名参会！</strong></span></p></section><p style="display: none;"><mp-style-type data-value="3"/></p></div>
个人中心
我是园区
退出
